Problem
Dependence on the centralised lab
Fragile patients must travel or send samples, which slows diagnosis and complicates follow-up.
PHHome-care patient · Waiting 24-48 h for a result
Market
Today, platelet monitoring is still slow and centralised
Follow-up for fragile patients depends on a distant lab: sampling, transport, analysis, then the result comes back. A slow journey that delays clinical decisions.
- Results available only after 24 to 48 hours
- Full dependence on the centralised laboratory
- Difficult travel and transport for fragile patients
Simulator
Model the economic potential of Track-T®
Consumable model: revenue follows usage. Adjust the assumptions.
1,000
6
15 €
90,000 €recurring revenue / year
6,000
tests sold / year
70,800 €
gross margin / year
0.25 %
of the French addressable market
Margin ~79 %Cost €3.2 / test
Indicative simulation.
Opportunity
A recurring, structured market ready to shift towards point-of-care diagnostics
Market volume
2.4 M
million reimbursed platelet counts in France every year
Addressable network
1000
Care facilities addressable across the country
Deployment channels
Home hospitalisation, health centres, private practices
Multiple deployment channels, already structured around local care.
Need
The problem HomePulse solves with Track-T®
A concrete clinical need, faced daily by home-care teams and fragile patients.
Situation
Broken follow-up and complications
Without a local solution, the care pathway can be interrupted, with a risk of hospitalisation and extra load for care teams.
Solution
Fast platelet monitoring, close to the patient
HomePulse enables a diagnosis in 15 minutes at home or in the clinic, with no difficult travel, integrated into local care.
Transformation
From today's pathway to the HomePulse pathway
Current pathway
Without HomePulse
- Result in 24 to 48 hours
- 24-48h
- Dependence on the centralised laboratory
- 100%
- Patient travel or sample transport
- Mandatory
- Coordination between nurse, lab and transport
- Complex
- Delayed clinical decisions
- Fragmented follow-up
- Risk of broken continuity
- High organisational load
HomePulse Track-T® pathway
With HomePulse
- Result in 15 minutes
- 15 min
- Diagnosis at home or in the clinic
- Decentralised
- Single use, integrated into care rounds
- Simplified
- Faster, better-informed clinical decisions
- Immediate
- Continuous, uninterrupted follow-up
- Lighter logistics
- Less coordination required
- Reduced organisational load
Origin
An innovation born from a real clinical frustration
HomePulse grew out of a field observation: when a biological result is not available at the moment it is needed, clinical decisions and continuity of care can be delayed. Setan, a nurse and healthcare entrepreneur, identified this need while working with patients and frontline professionals. Meeting Éléa, a biotechnology engineer, turned that clinical need into a technology project: Track-T®.
Setan
Co-founder · Community nurse & care coordinator
Éléa
Co-founder · Biotechnology engineer
Advantages
Why invest in HomePulse
A Medtech opportunity built on a concrete, frequent clinical need that is still far too dependent on the laboratory.
Innovation
Differentiated, patented Medtech
HomePulse offers a medical innovation aimed at a concrete, frequent clinical need, with a simple and scalable business model.
Market
Recurring and growing consumption
200,000 reimbursed platelet counts every month in France, with adoption potential across home hospitalisation, multi-professional practices, care networks and clinics.
Why the moment has come for HomePulse
Healthcare systems are moving towards more home care, more point-of-care diagnostics and less dependence on centralised pathways. HomePulse is part of this major shift towards care at home, supported by public policy and the expectations of care teams.
- ···
Acceleration of the shift to home care
- ···
Demand for point-of-care diagnostics
- ···
Clinics ready to adopt
- ···
Transformation of the healthcare system
Would you like to explore the opportunity?
Request the investor deck and access the key elements of the project: vision, market, product, business model and next steps.